|
Q3 FY2026
As of Aug 31, 2026
|
Q2 FY2026
As of May 31, 2026
|
Q1 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Nov 30, 2025
|
Q3 FY2025
As of Aug 31, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash | |||||
| Total Current Assets | |||||
| Total Assets | |||||
| Liabilities and Stockholders' Deficit | |||||
| Current Liabilities | |||||
| Short term business loan | |||||
| Loan from related parties, current | |||||
| Accounts payable and Accrued liability | |||||
| Due to related parties, current | |||||
| Total Current Liabilities | |||||
| Loan from related party | |||||
| Other non-current loan | |||||
| Total Non-Current Liabilities | |||||
| Total Liabilities | |||||
| Common stock $0.0001 par value; 500,000,000 shares authorized; 17,342,354 shares issued and outstanding as of August 31, 2026, and 14,670,000 shares issued and outstanding as of November 30, 2025 | |||||
| Preferred Stock Value | |||||
| Subscriptions receivable, equity | |||||
| Subscription receivable, equity | |||||
| Additional Paid-in Capital | |||||
| Accumulated deficit | |||||
| Total Stockholders' Deficit | |||||
| Total Liabilities and Stockholders' Deficit |
Loading...
